Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03511664
Title Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer (VISION)
Recruitment Active, not recruiting
Gender male
Phase Phase III
Variant Requirements No
Sponsors Endocyte

prostate cancer


lutetium Lu 177 vipivotide tetraxetan

Age Groups: adult | senior
Covered Countries USA | FRA | DEU | CAN | BEL

No variant requirements are available.